12 Jan 2022 ... Semenov, MD, MA, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, 40 Blossom St, Bartlett Hall 6R, Room 626, ...20 May 2016 ... Review in JAMA Dermatology journal See cases that were sent in https://t.co/LQTW8t8iTS…/ https://t.co/iTNrlbuzm3.Key Points. Question What is the long-term (up to 108 weeks) efficacy and safety of ixekizumab for pediatric patients with moderate to severe psoriasis?. Findings In this randomized clinical trial of 139 pediatric patients with plaque psoriasis, those who completed treatment with ixekizumab through week 108 achieved improvement in the Psoriasis …Bullous pemphigoid (BP) is the most common autoimmune-mediated subepidermal blistering skin disease and occurs mostly in elderly persons. The association of malignant neoplasms with BP has been controversial.1 This study compared the incidence of cancer in patients with BP with that of the age- and...Dermatology image-based AI algorithms must consider the unique features of dermatology data, which currently include a lack of standardization among imaging modalities and the risk of bias from noisy labels or demographically unrepresentative data. 2,14-16 These guidelines are intended as requirements for the consideration of study …Spironolactone is an androgen receptor antagonist that is an effective treatment for hormonally mediated acne. 1-4 Although generally well tolerated, spironolactone use is associated with hyperkalemia among patients with heart failure taking additional drugs that interfere with potassium excretion. 5 However, the prevalence of spironolactone-induced …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Key Points. Question What are the characteristics of patients older than age 85 years with nonmelanoma skin cancer receiving Mohs surgery?. Findings In this cohort study of 1181 patients older than age 85 years referred for Mohs surgery, those treated with Mohs surgery were more likely to have facial tumors and high functional status than those not treated …JAMA Dermatology. Full Text. Key Points. Question What are the recommended methods for early detection and prognostic assessment of cutaneous melanoma? Findings In this consensus statement, via a modified Delphi method, melanoma experts supported a risk-stratified approach to various aspects of melanoma screening as well as the use of visual …28 Dec 2022 ... Articles of the Year: JAMA Dermatology. For our sixth annual Articles of the Year roundup, we considered all Original Investigations, SpecialJAMA Dermatology. Key Points. Question Does the 9-valent human papillomavirus vaccine have therapeutic utility for cutaneous squamous cell carcinoma? Findings A woman in her 90s with multiple cutaneous squamous cell carcinomas was treated with the 9-valent human papillomavirus vaccine systemically and intratumorally. This approach led to regression …Chronic pruritus is a debilitating symptom that is associated with numerous dermatologic, neurologic, and systemic diseases. It is often resistant to treatment and can cause a severe reduction in quality of life. 1 Currently, to our knowledge, there is a lack of US Food and Drug Administration–approved therapies for pruritus, so treatment can be difficult and relies on …Aug 1, 2022 · Design, Setting, and ParticipantsThis was a multicenter, vehicle-controlled, double-blind, phase 3 randomized clinical trial (B-SIMPLE4) conducted in 55 clinics (mostly dermatology and pediatric) in the US from September 1, 2020, to July 21, 2021. JAMA Dermatology. Key Points. Questions What is the drug survival of adalimumab, ustekinumab, secukinumab, guselkumab, ixekizumab that is associated with effectiveness and safety in patients with psoriasis in the UK and Ireland, and are there any patient factors that are associated with survival of each biologic differently that could help treatment …JAMA Dermatology. Key Points. Question What is the efficacy and safety of bimekizumab in individuals with moderate to severe hidradenitis suppurativa (HS)? Findings In this double-blind, placebo-controlled, phase 2 randomized clinical trial including 90 randomized patients with HS (73 completed the trial), bimekizumab demonstrated clinically …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Key Points. Question What is the short-term and long-term comparative efficacy among biologics and oral agents for plaque psoriasis? Findings In a network meta-analysis of 60 clinical …Read the January 1, 2024 issue. Volume 160, Number 1.Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology is committed to patient privacy throughout the publication process 9; if the content of a submission is identifiable in any way—even if only to the patient or their family—permission should be obtained. For more information, refer to our Instructions for Authors of Images in Dermatology. 10. Back to top. Article InformationJAMA Dermatology. Key Points. Question What is the efficacy and safety of bimekizumab in individuals with moderate to severe hidradenitis suppurativa (HS)? Findings In this double-blind, placebo-controlled, phase 2 randomized clinical trial including 90 randomized patients with HS (73 completed the trial), bimekizumab demonstrated clinically …Generalized pruritus is a distressing symptom that can occur in several dermatologic and systemic disorders. 1 Generalized pruritus of unknown origin is that which affects patients without any underlying dermatologic or systemic disorder and is unassociated with rash. It most commonly occurs in older patients and persists for long periods, from months to years.JAMA Dermatology Patient Page. Measles. Bharath Balu, PhD; Eliot N. Mostow, MD, MPH. JAMA Dermatology. Measles (rubeola) is an infection caused by a highly contagious virus primarily spread by respiratory droplets. How Common Is Measles and How Contagious Is It? Measles is currently rare in the US because highly effective vaccines …Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons.Key Points. Question What is the prevalence of psoriasis in adults in the US, and how has prevalence changed since 2003?. Findings In this nationally representative cross-sectional study including 12 625 participants, the prevalence of psoriasis in adults in the US was 3.0%, indicating that more than 7.5 million adults 20 years or older have psoriasis. JAMA Dermatology. Audio (19:02) A Skin-Directed Scoring System for Epidermal Necrolysis. 1x. 0:00 / 0:00. Subscribe to Podcast. Full Text. Key Points. Question Is there a need for an EN skin-directed scoring system, consistent EN terminology, a better understanding of orphologic progression, and/or identification of the most-affected sites? ...Omega-3s were supposed to protect us all from heart disease and other health problems, but it’s taken some time for the evidence to catch up with the hype around these supplements....Read the January 1, 2024 issue. Volume 160, Number 1. To explore the degree of stigma toward individuals with acne and whether these attitudes vary based on characteristics of the individuals with acne or of the survey participants. Design, Setting, and ParticipantsIn this cross-sectional internet survey study, 4 stock portraits of adults that varied in sex (male/female) and skin tone (light/dark ...JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …A 63-year-old man with a history of chronic myeloid leukemia in complete remission after an allogeneic transplant received a diagnosis of PP via skin biopsy specimens 17 years after the transplant (Figure 1C).He had undergone multiple treatments, including photodynamic therapy (PDT), topical imiquimod, topical diclofenac, zinc oxide, tacalcitol, calcipotriol, …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Full Text. Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease characterized by recurrent flares and a family history of atopy. A hallmark feature of AD is epidermal barrier dysfunction that activates type 2 immune cells, which release Th2 cytokines (IL-4, IL-13, IL-31, and IL-22) that promote inflammation, B-cell IgE class …Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to respond to those. Nov 28, 2017 · Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings [MeSH]), and ... Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, cosmetic dermatology, and more. Formerly Archives of Dermatology. Jan 24, 2024 · The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology Clinicopathological Challenge . October 12, 2022. Numerous Angiomatous Lesions in an Infant. Catherine Reilly, BS 1; Nidhi Shah, MD 2; Kaiane Habeshian, MD 3. Author Affiliations Article Information. 1 Georgetown University School of Medicine, Washington, DC. 2 George Washington University School of Medicine and …Explore health information written for patients from JAMA Dermatology’s editors, including easy-to-understand explanations of atopic dermatitis, psoriasis, and more. Add to My …Medicine Matters Sharing successes, challenges and daily happenings in the Department of Medicine ARTICLE: Factors Associated With Overuse of Health Care Within US Health System AU...JAMA Dermatology. Full Text. Key Points. Question What are the recommended methods for early detection and prognostic assessment of cutaneous melanoma? Findings In this consensus statement, via a modified Delphi method, melanoma experts supported a risk-stratified approach to various aspects of melanoma screening as well as the use of visual …Wollenberg A , Barbarot S , Bieber T , et al; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and ... Interviews with authors of articles from JAMA Dermatology. JAMA Dermatology covers research on the skin, its diseases, and their treatment.Nov 28, 2017 · Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings [MeSH]), and ... Disclaimer: Dr Robinson is the editor of JAMA Dermatology but was not involved in the editorial review or the decision to accept the manuscript for publication. Additional Contributions: Steve Eilers, MD, Francisco Acosta, BA, Mark Anderson, MA, Hanz Blatt, MA, Rikki Gaber, BA, Yanina Guevara, BA, Ashley Juengling, BA, and Katie Reidy, MA, …JAMA Dermatology. Research. October 18, 2023. This systematic review and meta-analysis analyzes the risk of acne associated with Janus kinase (JAK) inhibitors across published phase 2 and 3 placebo-controlled randomized clinical trials of JAK inhibitors.Dr Shields is Assistant Section Editor of JAMA Dermatology, but she was not involved in any of the decisions regarding review of the manuscript or its acceptance. Meeting Presentation: This paper was presented at the 2022 Meeting of the American Academy of Dermatology; March 25, 2022; Boston, Massachusetts. Additional Contributions: We …Clean beauty, also known as natural skin care, is having a moment. From 2017 to 2018, the natural skin care market grew by 23% to 1.6 billion dollars, accounting for over 25% of the 5.6 billion dollars of annual skin care sales in 2018.1 Staunch warnings from influencers such as Gwyneth Paltrow,... Figures E-H are adapted from figures previously published in JAMA Dermatology. 10. Table 1. Summary of the BWH and AJCC 8 Tumor Classification Systems. View Large Download. Table 2. Evaluation of BWH and AJCC 8 Tumor Classification System Homogeneity and Monotonicity a. View Large Download. Table 3. Evaluation of BWH …In this issue of JAMA Dermatology, Boesjes et al 1 share their experience with patients with presumed atopic dermatitis (AD) who, shortly after dupilumab initiation, experienced worsening skin symptoms unlike their previous disease. Skin biopsies were characterized by atypical T-cell lymphocytic infiltrates. Although some of these patients developed …JAMA Dermatology. Key Points. Question Can tape strips serve as a minimally invasive approach to assess biomarkers for early-onset pediatric atopic dermatitis? Findings In this cross-sectional study of 51 children younger than 5 years with and without atopic dermatitis, the use of tape strips, a minimally invasive approach for …Dermatology | JAMA Network. Explore the latest in dermatology, including diagnosis and management of allergic, inflammatory, autoimmune and genetic diseases of the skin. JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Key Points. Question What are the long-term clearance rates of treatments used in patients with actinic keratosis? Findings This systematic review and network meta-analysis included data from 15 randomized clinical trials reporting sustained clearance rates after at least 12 months of treatment as a proxy for long-term efficacy. …This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with... JAMA Dermatology Clinicopathological Challenge . October 12, 2022. Numerous Angiomatous Lesions in an Infant. Catherine Reilly, BS 1; Nidhi Shah, MD 2; Kaiane Habeshian, MD 3. Author Affiliations Article Information. 1 Georgetown University School of Medicine, Washington, DC. 2 George Washington University School of Medicine and …Scalp dysesthesia was first described by Hoss and Segal 1 in 1998 as a cutaneous dysesthesia syndrome characterized by pruritus, burning, stinging, or pain of the scalp in the absence of any other unusual physical examination findings. In their case series of 11 patients, 5 patients had at least 1 known psychiatric disorder (dysthymic disorder, …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the …JAMA Dermatology Hair loss (alopecia) is categorized as scarring (with permanent destruction of hair follicles) or nonscarring. Nonscarring alopecia is the most common form of hair loss and can be classified as patterned, diffuse, or focal, based on the distribution of hair loss.This case series involved a chart review of 3 patients with alopecia associated with the use of a detangling hairbrush (eFigure in Supplement 1) seen at our center between 2020 and 2022.The National Healthcare Group Domain Specific Review Board approved the study (approval reference 2022/00672), and patients provided written informed consent.Introduction Acne often persists into adulthood in women. However, few studies have specifically explored the lived experience of acne in adult populations. Objective To examine the lived experience of acne and its treatment among a cohort of adult women.. Design, Setting, and Participants A qualitative analysis was conducted from free listing and open …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. Oct 2, 2019 · Key Points. Question What is the efficacy and safety of abrocitinib monotherapy in patients with moderate-to-severe atopic dermatitis?. Findings In this randomized clinical trial of 391 patients 12 years or older with moderate-to-severe atopic dermatitis, significantly greater proportions of patients treated with abrocitinib (200 mg or 100 mg) compared with placebo achieved an Investigator ... Looking for the perfect acne treatment that works for your type of acne *and* your skin type? Check out our derm-approved picks for the best acne treatments. We include products we...JAMA Dermatology. Key Points. Questions What is the drug survival of adalimumab, ustekinumab, secukinumab, guselkumab, ixekizumab that is associated with effectiveness and safety in patients with psoriasis in the UK and Ireland, and are there any patient factors that are associated with survival of each biologic differently that could help treatment …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Dec 1, 2018 · Little evidence exists to guide the management of moderately dysplastic nevi excisionally biopsied without residual clinical pigmentation but with positive histologic margins (hereafter referred to as moderately dysplastic nevi with positive histologic margins). To determine outcomes and risk for the development of subsequent cutaneous melanoma ... Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Key Points. Question What are the characteristics of patients older than age 85 years with nonmelanoma skin cancer receiving Mohs surgery?. Findings In this cohort study of 1181 patients older than age 85 years referred for Mohs surgery, those treated with Mohs surgery were more likely to have facial tumors and high functional status than those not treated …2023;159 (3):247-248. doi:10.1001/jamadermatol.2022.6162. Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis. Atopic dermatitis (AD) is a …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ...
Jan 7, 2013 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) . Gif cutter
Authors of manuscripts based on clinical images should consult the instructions for. Provide a short title that briefly describes the disease entity or case presentation and does not include the diagnosis. Do not include the patient's race, ethnicity, or country of origin in the title or first line of the article.23 Aug 2022 ... Scopus has been covering JAAD, JAMA-D and AJCD since 1979, 2013 and 2000, respectively. In total: JAAD published 17,065 research articles. A ...Archives of Dermatology Reader's Choice: Continuing Medical Education · Citation · We recommend · JAMA Dermatology · JAMA Network · Help.JAMA Dermatology. Audio (19:02) A Skin-Directed Scoring System for Epidermal Necrolysis. 1x. 0:00 / 0:00. Subscribe to Podcast. Full Text. Key Points. Question Is there a need for an EN skin-directed scoring system, consistent EN terminology, a better understanding of orphologic progression, and/or identification of the most-affected sites? ...JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology …Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to …Explore the latest in dermatology, including diagnosis and management of allergic, inflammatory, autoimmune and genetic diseases of the skin.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …From a policy perspective, it is hard to understand the Modi government’s approach towards education. Sarwari Jahan is an Accredited Social Health Activist in her early 30s who wor...Importance: Atopic dermatitis (AD) is a chronic, recurrent, inflammatory skin disease with an unmet need for treatments that provide rapid and high levels of skin clearance and itch improvement. Objective: To assess the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-severe AD. Design, setting, and participants: …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …9 Aug 2023 ... Kwatra, MD, Department of Dermatology, Johns Hopkins University School of Medicine, 1550 Orleans St, Koch CRBII, Room 206, Ste 216, Baltimore, ...Oct 2, 2019 · Key Points. Question What is the efficacy and safety of abrocitinib monotherapy in patients with moderate-to-severe atopic dermatitis?. Findings In this randomized clinical trial of 391 patients 12 years or older with moderate-to-severe atopic dermatitis, significantly greater proportions of patients treated with abrocitinib (200 mg or 100 mg) compared with placebo achieved an Investigator ... JAMA Dermatology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2168-6068.JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and ... JAMA Dermatology. Full Text. Key Points. Question What were the outcomes for patients with clinically and histologically confirmed Hailey-Hailey disease who were treated with superficial radiotherapy? Findings In this case series of 13 patients with Hailey-Hailey disease, 56 of 62 separate body areas (90%) and 9 of 13 patients (69%) responded with …Medicine Matters Sharing successes, challenges and daily happenings in the Department of Medicine ARTICLE: Factors Associated With Overuse of Health Care Within US Health System AU....